Tag: Glenmark Pharmaceuticals
Glenmark Launches SUTIB (Sunitinib) – Priced 96% Lower than the Innovator Brand
KOCHI:Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today launched SUTIB, the generic version of.
Glenmark Launch Remogliflozin + Vildagliptin Fixed Dose Combination for Type 2 Diabetes
KOCHI:Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed dose combination.
Glenmark Introduces NINDANIB (Nintedanib) at an Affordable Cost
KOCHI:Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today launched NINDANIB (Nintedanib 100 and 150.
Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir
KOCHI: Glenmark Pharmaceuticals Ltd. – a global research-led pharmaceutical company – today announced top-line results.
Glenmark Commences 1000 Patients Post Marketing Surveillance Study with COVID-19
KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced.
Glenmark Initiates Phase 3 Clinical Trials on Antiviral Favipiravir
KOCHI: Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials.
Glenmark Pharmaceuticals Announces Launch of Latest-in-class Diabetes Medicine
KOCHI: Glenmark Pharmaceuticals Ltd (Glenmark), a research-led global integrated pharmaceutical company, today announced the launch of.
HC Finds Pharma Co Guilty in Infringement Case, Asks to Give Rs 1.50 Cr for Kerala Flood Relief
MUMBAI: The Bombay High Court has ordered a pharmaceutical company to deposit Rs 1.50 crore.